Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01596751
Title Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hope Rugo, MD
Indications

breast cancer

Therapies

Eribulin

Pexidartinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.